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Abstract 
Vitamin A deficiency leads to an increased susceptibility to infections, increased severity of infections and increased mortality. 
Because the neutrophil s the first cell to respond to infection, this study explores the effect of vitamin A deficiency on neutrophil 
proteinases. We found that neutrophils from vitamin A-deficient rats had lower levels of two cathepsin G-like enzymes (28 and 24 kDa) 
when compared to neutrophils from weight-matched pair-fed rats, vitamin A-deficient rats which were repleted with retinyl palmitate and 
nonrestricted vitamin A complete diet rats. The 28 kDa cathepsin G-like enzyme, which migrated with the same mobility as elastase on 
SDS-polyacrylamide g ls, was quantified using Western blots. The 24 kDa cathepsin G-like enzyme was quantified using zymogram gels. 
This activity was inhibited by chymostatin. Other neutrophil proteinases, elastase, plasminogen activators and gelatinase, were not altered 
significantly by vitamin A deficiency. The low levels of cathepsin G may contribute to differences in the inflammatory process observed 
under vitamin A deficiency. 
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1. Introduction 
Vitamin A deficiency is associated with the loss of 
vision [1] and an increased rate of infection, severity of 
infections and mortality in humans [2,3]. This increase is 
observed even in the early stages of the deficiency. HIV-1 
infected individuals with mild deficiency (plasma retinol < 
1 /zM) experience increased mortality by a factor of six 
when compared to HIV-1 infected individuals with plasma 
retinol evels of 1-4/xM [4]. 
The neutrophil s the first inflammatory cell to respond 
to an infection in most tissues, including the cornea [5]. 
Neutrophils are targeted to the site of infection by chemo- 
tactic stimuli. They then phagocytose, kill, and digest the 
invading organisms. These cells store a number of prote- 
olytic enzymes in their granules. The serine proteinases: 
cathepsin G, elastase and proteinase 3 are found in their 
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active forms in the azurophilic granules [6]. Plasminogen 
activator is stored in the specific granules [7]. The pro- 
forms of the matrix metalloproteinases, gelatinase B and 
collagenase, are also found in the specific granules [7]. In 
addition, progelatinase B is present in gelatinase-contain- 
ing granules [8]. 
The synthesis of neutrophil proteins, including pro- 
teinases, occurs at specific times during the maturation of 
these cells. Azurophilic granule proteinases, cathepsin G, 
elastase and proteinase 3, are synthesized uring the 
myeloblast and promyelocyte stages [7]. Specific granule 
proteinases, plasminogen activator and collagenase, are 
synthesized uring the myelocyte and metamyelocyte 
stages [7]. Gelatinase B, found in gelatinase-specific gran- 
ules, is synthesized uring the band cell stage and is a 
marker for terminal differentiation of these cells [9]. 
In the human, there are three forms of elastase and four 
forms of cathepsin G. These forms differ by the type of 
carbohydrates attached to the enzymes [10]. The four 
cathepsin G isoforms range in size from 23.5 to 26 kDa on 
SDS-polyacrylamide g ls. In the rat, two forms of cathep- 
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sin G are detected on gradient SDS-polyacrylamide g ls 
[ll]. 
Progelatinase B (92 kDa) is the major gelatinase found 
in neutrophils [12]. Antibodies to this enzyme react with 
bands at 135 and 225 kDa in addition to the 92 kDa band. 
The 135 kDa band is a complex composed of progelatinase 
B and the neutrophil gelatinase-associated lipocalin [13]. 
This latter molecule binds small lipids. The 225 kDa band 
is a dimer of the progelatinase B. Upon neutrophil, activa- 
tion, multiple activation products are observed for neu- 
trophil gelatinase B [14]. The initial activation product has 
a molecular weight of 84 kDa and the most stable interme- 
diate is a 70 kDa form. 
The purpose of the present work is to characterize the 
effect of vitamin A deficiency on neutrophil proteinases. 
We studied the cathepsin G, elastase, plasminogen activa- 
tors and gelatinases present in and released by neutrophils 
from vitamin A-deficient rats (A - ) ,  A -  rats repleted 
with retinyl palmitate (R), weight-matched pair-fed control 
rats (A + ), and non-restricted vitamin A-complete rats 
(N). 
2. Materials and methods 
2.1. Materials 
Autoclavable vitamin A-deficient diet and the control 
diet with retinyl palmitate added back (15 mg/kg) were 
purchased from Harlan-Sprague Dawley-Teklad (Madison, 
WI, USA). Heparin was obtained from Elkins-Sinn (Cherry 
Hill, NJ, USA). Retinol, ascorbic acid and HPLC chro- 
matography solvents were from J.T. Baker (Phillipsburg, 
N J, USA). Hexane was purchased from Sigma-Aldrich 
(Milwaukee, WI, USA). Dextran T500 was obtained from 
Pharmacia (Uppsala, Sweden). The proteinase inhibitors 
phenylmethylsulfonyl fluoride (PMSF), chymostatin, pep- 
statin, E-64 (L-trans-epoxysuccinyl-leucyl amide-(4- 
guanidino)-butane-N-[ N-L-3-transcarboxythine-2-carboxyl- 
L-leucyl)-agmatine) and ethylenediaminetetraacetate 
(EDTA) were purchased from Sigma (St. Louis, MO, 
USA). Staphylococcus A antibody, pyrogallol, retinyl 
palmitate, retinyl acetate, zymosan, Histopaque, gelatin 
and other miscellaneous compounds used for buffers were 
also purchased from Sigma. Casein was from Nutritional 
Biochemical (Cleveland, OH, USA). Cathepsin G, elastase 
and rabbit anti-human cathepsin G and elastase antibodies 
were purchased from Athens Research Technology 
(Athens, GA, USA). Pentobarbital was purchased from 
Abbott Laboratories (North Chicago, IL, USA). LeukoStat 
staining kit was from Fisher Diagnostics (Orangeburg, NY, 
USA). Carnation non-fat dry milk was from Nestle Food 
Products (Glendale, CA, USA). Enhanced chemilumines- 
cence kit, ECL, was purchased from Amersham (Arlington 
Heights, IL, USA). Peroxidase conjugated goat anti-Rabbit 
IgG was obtained from Bio-Rad Laboratories (Hercules, 
CA, USA). Urokinase and tissue plasminogen activator 
were a kind gift from Richard Marlar Ph.D. (University of 
Colorado, Denver, CO, USA). 
2.2. Vitamin A-deficient and control rats 
WAG/Ri j /MCW rats were raised in a defined flora 
colony where they were exposed to a restricted number of 
bacterial species (Enterococcus, Enterobacter cloacae, Es- 
cherichia coli, Bacillus sp,, Providence rettgeri, Staphylo- 
coccus epidermis and aureus, and Streptococcus faecalis) 
but not to mycoplasma or viruses. Nursing females were 
placed on the autoclavable casein-based vitamin A-defi- 
cient diet 16 days post partum. At 21 days of age, the 
weaned male pups were divided into four dietary groups: 
(1) 10 rats (A - ) were placed on a casein-based retinoid- 
deficient diet. (2) 10 rats (R) were placed on the retinoid- 
deficient diet for 80 days. On that day, the rats were fed 
500 /zg retinyl palmitate in 200 /zl safflower oil and then 
given free access for 16 days to the retinyl palmitate-supp- 
lemented control diet (vitamin A-deficient diet supple- 
mented with retinyl palmitate at 15 mg/kg). (3) 10 rats 
(A + ) were restricted in their intake of the retinyl palmi- 
tate-supplemented diet so that their weight gain matched 
that of the A -  rats. (4) 10 non-restricted (N) rats were 
given free access to the retinyl palmitate-supplemented 
diet. All rats were weighed every 3 or 4 days to monitor 
the progress of the deficiency. 
On the last day of the experiment (96 days on the diet; 
117 days of age), each rat was anesthetized with 
methoxyflurane and bled by heart puncture using heparin 
as an anticoagulant [15]. The blood was used for the 
isolation of neutrophils and the determination of plasma 
retinol concentration. The animals were then killed using 
an overdose of pentobarbital. Livers were removed and 
stored at -80°C until extracted for retinoids. All proce- 
dures were carried out under yellow lights to preserve the 
retinoids. All samples were stored either in foil or in 
yellow tubes for protection from light. 
The rat protocols used in these experiments were ap- 
proved by the Animal Care Committee of the Medical 
College of Wisconsin and comply with the Guide for the 
Care and Use of Laboratory Animals [16]. 
2.3. Lir'er and serum retinoid concentration determination 
Serum retinoids were extracted using hexane in the 
presence of 5.7 mmol/1 ascorbic acid [17]. The entire liver 
was weighed, homogenized, saponified and extracted using 
hexane in the presence of 80 mmol/l pyrogallol [18,19]. 
As an internal standard, retinyl acetate was added to all 
samples prior to extraction. The samples were solubilized 
in ethanol and separated by HPLC (Dionex; Sunnyvale, 
CA, USA) on a Whatman (Hillsboro, OR, USA) EQC 
125A Cj8 column (4.6 mm I.D. × 108 ram) using a linear 
gradient of MeOH/H20 (90:10, v /v )  and ethyl 
acetate/isopropanol (90:10, v /v)  at a flow rate of 1.0 
ml/min [20]. 
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2.4. Neutrophil isolation and extraction 2.7. Western blots 
Neutrophils were isolated from heparinized blood using 
dextran sedimentation followed by separation on a 
Histopaque density gradient [15]. Preparations containing 
at least 95% neutrophils were used for the studies reported 
here. 
A portion of the purified neutrophils was homogenized 
in PBS and then hexadecyltrimethylammonium bro ide 
(HTM) was added to a final concentration of 0.5%. The 
homogenates were frozen and thawed three times, cen- 
trifuged (13 000 × g) and the supernatant fraction stored at 
-80°C. In some extracts, HTM was omitted to determine 
whether the proteinases required a detergent for extraction. 
The neutrophil supernatant fraction was separated on 
SDS-polyacrylamide gels under non-reducing conditions 
[22] and electroblotted onto nitrocellulose. The blots were 
blocked with non-fat dry milk, washed, reacted with either 
rabbit anti-human cathepsin G or elastase antibodies, 
washed, reacted with peroxidase conjugated goat anti-rab- 
bit IgG antibodies, and visualized by the method recom- 
mended by the ECL kit. The intensity of the protein 
chemiluminescent bands was measured on an AMBIS 
imaging system and compared to a standard curve of 
cathepsin G or elastase. 
2.8. Statistical analysis 
2.5. Neutrophil activation 
Isolated neutrophils (1 × 10 7 in 0.45 ml of PBS) were 
activated at 37°C by the addition of 5 /xg cytochalasin B 
and 50 /zl PBS containing 1.25 mg opsonized zymosan in 
suspension for 1 h and then centrifuged at 4°C. 
2.6. Zymography for detection of proteinases 
Statistical analysis of the data was performed using 
SigmaStat Statistical Software (Jandel Scientific Software, 
San Rafael, CA, USA). The one-way analysis of variance 
was used after testing for normality and equal variance to 
determine whether an overall difference existed between 
the A - ,  R, A + and N groups of data [23]. The Student- 
Newman-Keuls' procedure was used to determine individ- 
ual differences within the groups [24]. 
All values are given _+ SD. 
Proteinases in the neutrophil supernatant fractions were 
resolved on either 9 or 12% sodium dodecyl sulfate (SDS) 
polyacrylamide g ls containing 0.2% casein or 0.1% gelatin 
[21]. Plasminogen activator gels contained both 0.2% ca- 
sein and 16 /zg/ml plasminogen. Gels contained serial 
dilutions of cathepsin G, elastase, plasminogen activators 
and metalloproteinases. Samples, normalized for the num- 
ber of neutrophils, were mixed with sample buffer without 
reducing agents. The molecular weight protein standards 
were electrophoresed in the presence of 20 mM dithiolthre- 
itol. After electrophoresis, the gels were washed, incubated 
overnight and then stained with Coomassie brilliant blue 
R-250 according to the procedure of Herron et al. [21]. The 
proteinase bands appeared as clear unstained bands in a 
field of blue stained protein. The proteinase bands were 
quantified on an AMBIS imaging system and compared to 
a standard curve of the measured proteinase. 
In order to determine the type of proteinases observed 
on the zymograms, the samples were mixed with inhibitors 
or the solvent and incubated for 60 min at room tempera- 
ture prior to electrophoresis. After electrophoresis, the gels 
were washed and incubated in buffers which also con- 
tained the inhibitors. The final concentrations of inhibitors 
used were 1 mM PMSF, 100 /zM chymostatin, 1 /zM 
pepstatin, 10/~M E-64 and 4 mM EDTA. Control samples 
and gels were incubated with the solvents used for the 
inhibitors (1 mM HC1 for TLCK, isopropanol for PMSF, 
H20 for EDTA and E-64, dimethyl sulfoxide (DMSO) for 
chymostatin and methanol for pepstatin). 
3. Results 
3.1. Characterization of the vitamin A-deficient rats 
The average weight of the 10 A -  rats at the early 
weight plateau stage (day 63 of age) was 197 + 5 g and it 
stayed in this range (_+ 2 g) until the animals were killed 
on day 96. The 10 A + rats averaged 194 ___ 6 g between 
day 63 and day 96. The 10 N rats continued to gain weight 
over this period of time with an average final weight of 
293 + 6 g. The 10 R rats were given retinyl palmitate on 
day 80 and then fed the vitamin A containing diet from 
day 80 to 96. These rats gained 3.6 + 0.3 g/day for a final 
average weight of 255 + 4 g. Serum and liver retinol 
concentrations of the rats used in this study were deter- 
mined to confirm the vitamin A status of these animals. 
The rats at the time of sacrifice had serum retinol levels of 
<8 nmol/1 for the A -  rats, 387+11 nmol/ l  for the 
A + rats, 824 + 14 nmol/1 for the R rats and 887 + 15 
nmol/ l  for the N rats. The total liver retinol levels of < 1 
nmol/g for the A - rats, 548 + 84 nmol/g for the A + 
rats, 216 + 45 nmol/g for the R rats and 574+ 120 
nmol/g for the N rats. The lower plasma retinol levels in 
the plasma of the A + rats reflect the typical protein 
malnutrition of these rats due to restricted food uptake. 
Sixteen days of retinol repletion were not adequate for this 
group of animals to completely restore liver retinol stores 
but was adequate to restore plasma levels of this vitamin. 
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Fig. 1. Effect of vitamin A deficiency on neutrophil enzymes that degrade 
casein. Representative HTM extracts of neutrophils, normalized for the 
number of cells (2.0x104), were electrophoresed on casein (0.2%) 
containing SDS-polyacrylamide g ls and processed for visualization of 
proteinases. 
3.2. Caseinolytic enzymes in neutrophils from vitamin 
A-deficient and control rats 
Isolated neutrophils were extracted in the presence of 
the detergent HTM and the supernatant fractions used for 
the study of neutrophil proteinases. Casein zymograms of 
the neutrophil extracts revealed two major bands of ca- 
seinolytic activity at 28 and 24 kDa in the A +,  R and N 
neutrophil extracts (Fig. 1). Some of the samples from the 
N rats also had a minor band at 17 kDa. The 24 kDa band 
was either not observed in the A - neutrophil samples or 
barely visible. The lower amounts of the 24 kDa enzyme 
in the A + sample relative to the R and N samples may be 
related to the lower plasma retinol concentrations in the 
A + rats. The 24-kDa band was not inhibited by the 
metalloproteinase inhibitor, EDTA; the cysteine proteinase 
inhibitor, E-64 (Fig. 2); nor the aspartate proteinase in- 
hibitor, pepstatin (data not shown). It was inhibited by the 
serine proteinase inhibitor, PMSF, and the cathepsin G 
inhibitor, chymostatin. These results suggest he 24 kDa 
band is a cathepsin G-like enzyme. This lower band was 
present only in samples extracted with the detergent HTM 
(data not shown). This suggests that the 24-kDa enzyme is 
II;.'111111 -28  kDa - 24  kDa 
£ B '"  =o ._ ,= 
cI  ~ o 
¢0 
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Fig. 2. Inhibition of the neutrophil enzymes thatdegrade casein. The N rat 
neutrophil extracts were incubated for 60 min with either an inhibitor or 
the vehicle used to solubilize the inhibitor. The incubated extracts were 
electrophoresed on casein (0.2%) containing SDS-polyacrylamide gels. 
After electrophoresis, the gels were processed for proteinase activity in 
the presence of the inhibitors or the vehicles used to solubilize the 
inhibitor. After incubation, the gels were stained for visualization of the 
proteinases. All samples applied contained 2.1 × 104 neutrophils (except 
chymostatin 2 and the vehicle control DMSO 2 which contained 1.8 × 105 
neutrophils). 
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Fig. 3. Identification of cathepsin G and elastase in neutrophil extracts 
using Western blots. Representative samples of neutrophil proteins were 
electrophoresed on SDS-polyacrylamide g ls, transblotted to nitrocellu- 
lose and reacted with either rabbit anti human cathepsin G (A) or elastase 
(B) IgG. The blots were incubated with goat anti-rabbit IgG antibodies 
conjugated with peroxidase and then reacted with ECL kit. The resulting 
chemiluminescence was recorded using X-ray film. 
membrane bound. No cross reaction was observed between 
this 24 kDa enzyme and rabbit polyclonal antibodies to 
human cathepsin G (Fig. 3). 
The 28-kDa band on the casein gel was also decreased 
under vitamin A deficiency (Fig. 1). The relative activity 
(in arbitrary units) was determined by densitometric mea- 
surement is 25.6 + 10.2 (n = 10) for the A -  extracts, 
46.1 _ 15.4 (n = 10) for the A + extracts, 52.6___ 14.4 
(n = 10) for the R extracts and 77.9 + 20.1 (n = 10) for 
the N extracts. (P  < 0.05 for A - vs. A +,  R and N; A + 
and R vs. N). This band was totally inhibited by the serine 
proteinase inhibitor PMSF (Fig. 2). In the presence of 
EDTA, the intensity of the upper 28 kDa band was en- 
hanced. This band was partially inhibited by the organic 
solvents, isopropanol and DMSO, which were used as 
carriers for PMSF and chymostatin, respectively. At low 
levels of the neutrophil extract (2.1 × 10 4 cells applied), 
chymostatin did not significantly alter the cleavage of 
casein within the gels by the 28 kDa proteinase. However, 
at higher levels of the neutrophil extract (1.8 × 105 cells 
applied), chymostatin partially inhibited this band. These 
results suggested the presence of both elastase and cathep- 
sin G in this band. This was confirmed by cross-reaction of
the rat enzymes with antibodies to human elastase and 
cathepsin G (Fig. 3). The levels of elastase from one 
sample to another were extremely variable with no signifi- 
cant differences in the amount of elastase between the 
neutrophil samples from the A -  rats and those from the 
control A +,  R and N rats. The amount of cathepsin G 
present in the 28 kDa band determined by densitometry of
Western blots was significantly lower in the A -  neu- 
trophil extract relative to the control extracts. Cathepsin G 
concentrations present per 107 cells were 1.9 ___ 1.2 /xg 
(n -= 4) for the A - samples, 5.6 + 1.0 /xg (n = 4) for the 
A + samples, 7.1 ___ 0.4/xg (n = 4) for the R samples and 
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8.8 + 5.5 /.~g (n = 4) for the N samples. (P < 0.01 for 
A - vs A +,  R and N samples) These results suggest hat 
both forms of cathepsin G are decreased under A - condi- 
tions relative to the normal control conditions. 
3.3. Plasminogen activators in neutrophils from vitamin 
A-deficient and control rats 
The concentrations of other neutral neutrophil pro- 
teinases were not altered by the deficiency. The pattern of 
plasminogen activators present in the cells was the same in 
most of the A - neutrophils relative to the A +,  R and N 
neutrophils (Fig. 4). While some of the A -  neutrophil 
samples had lower levels of the 40 kDa form and/or very 
little of the 60/63 kDa plasminogen activator forms (com- 
igrated with human tissue type plasminogen activator) 
(Lane A - 1), densitometric comparisons of the plasmino- 
gen activator forms revealed no significant differences 
between the A - ,  A +,  R and N neutrophil samples 
(n = 6 for A - ,  A +,  R and N). 
3.4. Gelatinases in neutrophils from vitamin A-deficient 
and control rats 
One major gelatinase at 92 kDa and two minor bands at 
135 and 225 kDa were observed in nonactivated neu- 
trophils from A - ,  A +,  R and N rats extracted with 0.5% 
HTM (data not shown). No significant differences were 
detected by densitometric analysis in the concentrations of
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-51  kDa 
-50  kDa 
-43  kDa 
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Fig. 5. Identification of gelatinases in A- ,  A+,  R and N rat activated 
neutrophil extracts. Equal numbers of cells were activated with zymosan 
and cytochalasin B for 2 hrs. The supernatant fractions (loaded for 
maximal activation bands) were electrophoresed on SDS-polyacrylamide 
gels containing elatin (0.1%) and processed for protemase visualization. 
these gelatinases present in the neutrophils from the A - ,  
A +,  R and N rats (n = 10 for each group). Upon activa- 
tion of neutrophils from the A - ,  A +,  R and N rats, the 
concentrations of the different activated forms of gelati- 
nases were similar as determined by densitometric analysis 
(Fig. 5). All gelatinase bands were inhibited by EDTA 
with the exception of a faint 28 kDa band which was 
inhibited by PMSF (data not shown). This activity is 
probably due to elastase and/or cathepsin G. 
4. Discussion 
A 
=" =" 1 2 1 2 1 2 1 2 
~='g= A- A+ R N 
B 
-90 kDa 
.63 k a 
-60 k~a 
-40 kDa 
-28 kDa 
-90 kDa 
-28 kDa 
~" ~ 1 2 1 2 1 2 1 2 
"g'g= A-  A+ R N 
Fig. 4. Comparison of plasminogen activators in neutrophil extracts from 
A-  and control rats. Representative samples of extracted neutrophils, 
normalized for the number of cells, were electrophoresed on casein 
(0.2%) (B) and casein (0.2%) plus plasminogen (16 /xg/ml) (A) contain- 
ing SDS-polyacrylamide g ls. The gels were then processed for visualiza- 
tion of the proteinases. (h-upa = human urokinase type plasminogen 
activator; h-tpa = human tissue type plasminogen activator). 
The major difference in the proteinase populations pre- 
sent in the A - vs A +,  R and N control neutrophils is a 
decrease in the 24 and 28 kDa forms of cathepsin G. The 
24 kDa form was identified as a cathepsin G-like enzyme 
based on its inhibition by the serine proteinase inhibitor, 
PMSF, and the cathepsin G/chymotrypsin i hibitor, chy- 
mostatin. Of the two forms of rat neutrophil cathepsin G, 
only the 28 kDa form cross reacted with antibodies to the 
human enzyme. This lack of observable cross reaction with 
the 24 kDa form may reflect a lower amount of enzyme 
present or a true lack of cross reactivity. The two forms 
may differ based on the presence or absence of complex 
type carbohydrates in a similar manner to differences 
observed for human cathepsin G [10]. 
The difference in cathepsin G concentrations under 
vitamin A deficiency conditions relative to control condi- 
tions is not due to a deficiency in retinoids in the bone 
marrow during synthesis of this enzyme. Synthesis occurs 
in the bone marrow during the myeloblast and promyelo- 
cyte stage [7]. We recently showed that retinol is se- 
questered in the bone marrow of vitamin A-deficient ani- 
mals with levels 4-fold higher in the A -  rats relative to 
control rats [25]. It is only when neutrophils are released 
into the circulatory system that the cells are subjected to 
low retinol conditions (< 8 nmol/1). The alterations in 
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cathepsin G levels in these cells could be due to decreased 
synthesis of the enzyme at the higher retinol levels present 
in the bone marrow of the A - rats. Alternatively, cathep- 
sin G may be sensitive to degradation either at the higher 
than normal retinol levels in the bone marrow of A - rats 
or at the very low retinol concentrations found in the blood 
of these rats. 
The adequate levels of retinoids present in the bone 
marrow during the synthesis of plasminogen activators and 
matrix metalloproteinases is probably the reason no signifi- 
cant differences were observed in the amounts of these 
enzymes in the neutrophils of the A - ,  A +,  R and N 
rats. However, in other tissues the levels of these enzymes 
are altered by vitamin A deficiency [26,27]. 
In contrast o the 28 kDa cathepsin-G like enzyme, the 
24 kDa cathepsin G-like enzyme requires the presence of a 
detergent for extraction. This suggests it is probably mem- 
brane bound. This form may bind to the plasma membrane 
through an electrostatic mechanism similar to that eluci- 
dated for human neutrophils [28,29]. 
A decrease in neutrophil cathepsin G in the vitamin 
A-deficient animals is significant because cathepsin G not 
only is involved with the degradation of phagocytosed 
materials, it also has several other functions. It influences 
the activity of other proteinases [30-34]. The release of 
elastase from neutrophils requires this enzyme [30,31]. 
Cathepsin G can activate both neutrophil (progelatinase B 
and procollagenase) [32,33], and host tissues (pros- 
tromelysin) matrix metalloproteinases [34]. In addition, 
cathepsin G is required for chemotaxis of neutrophils [35] 
and acts as an antimicrobial polypeptide [36]. 
Evidence for the importance of cathepsin G was shown 
in a model of corneal ulceration under vitamin A defi- 
ciency conditions [15]. Eighteen hours after low amounts 
of Pseudomonas aeruginosa (10 4 cfu) were applied to 
scratched corneas, central ulcers containing recoverable 
organisms were observed on the A - corneas. In contrast, 
the A + and N corneas did not ulcerate and no bacteria 
were recovered from the corneas. When 107 to 10 8 Pseu- 
domonas aeruginosa organisms were applied topically to 
the scratched corneas, the numbers of total neutrophils 
present in the corneas were similar in the A - ,  A +,  R 
and N rat corneas, yet, the extent of corneal degradation 
was 2-fold greater in the A +,  R and N corneas relative to 
the A - corneas. These experiments suggested there was a 
difference in the activation of the neutrophils and/or the 
activity or concentrations of secreted proteinases [15]. 
In conclusion, both the 28 and 24 kDa forms of rat 
cathepsin G are significantly reduced in the neutrophils of 
A - rats when compared to those of A +,  R and N rats. 
The deficiency probably alters significantly the function of 
the neutrophils from A - rats in two ways: (1) by decreas- 
ing the direct cleavage of phagocytosed and extracellular 
proteins and the activation of matrix metalloproteinases 
and (2) by decreasing nonoxidative killing of bacteria 
through peptide antimicrobial activity. 
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